Skip to main content
Top
Published in: Neurological Sciences 1/2009

01-05-2009 | Oral Communication

Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data

Authors: Alberto Proietti Cecchini, Eliana Mea, Vincenzo Tullo, Marcella Curone, Angelo Franzini, Giovanni Broggi, Mario Savino, Gennaro Bussone, Massimo Leone

Published in: Neurological Sciences | Special Issue 1/2009

Login to get access

Abstract

Drug refractory chronic daily headache (CDH) is a highly disabling condition. CDH is usually regarded as the negative evolution of chronic migraine (CM) and is characterized by high prevalence of psychiatric disorders, especially mood disorders. Vagal nerve stimulation (VNS) is an established treatment option for selected patients with medically refractory epilepsy and depression. Neurobiological similarities suggest that VNS could be useful in the treatment of drug-refractory CM associated with depression. The aim of the study was to evaluate the efficacy of VNS in patients suffering from drug-refractory CM and depressive disorder. We selected four female patients, mean age 53 (range 43–65 years), suffering from daily headache and drug-refractory CM. Neurological examination and neuroradiological investigations were unremarkable. Exclusion criteria were psychosis, heart and lung diseases. The preliminary results in our small case series support a beneficial effect of chronic VNS on both drug-refractory CM and depression, and suggest this novel treatment as a valid alternative for this otherwise intractable and highly disabling condition.
Literature
1.
go back to reference D’Amico D, Leone M, Grazzi L, Bussone G (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis? Neurol Sci 29(Suppl 1):S55–S58PubMedCrossRef D’Amico D, Leone M, Grazzi L, Bussone G (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis? Neurol Sci 29(Suppl 1):S55–S58PubMedCrossRef
2.
go back to reference Diener HC, Küper M, Kurth T (2008) Migraine-associated risks and comorbidity. J Neurol 255(9):1290–1301PubMedCrossRef Diener HC, Küper M, Kurth T (2008) Migraine-associated risks and comorbidity. J Neurol 255(9):1290–1301PubMedCrossRef
3.
4.
go back to reference Jette N, Patten S, Williams J, Becker W, Wiebe S (2008) Comorbidity of migraine and psychiatric disorders–a national population-based study. Headache 48(4):501–516PubMedCrossRef Jette N, Patten S, Williams J, Becker W, Wiebe S (2008) Comorbidity of migraine and psychiatric disorders–a national population-based study. Headache 48(4):501–516PubMedCrossRef
5.
go back to reference DeGiorgio CM, Schachter SC, Handforth A et al (2000) Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 41(9):1195–1200PubMedCrossRef DeGiorgio CM, Schachter SC, Handforth A et al (2000) Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 41(9):1195–1200PubMedCrossRef
6.
go back to reference Nahas Z, Marangell LB, Husain MM et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104PubMedCrossRef Nahas Z, Marangell LB, Husain MM et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104PubMedCrossRef
7.
go back to reference Multon S, Schoenen J (2005) Pain control by vagus nerve stimulation: from animal to man…and back. Acta Neurol Belg 105:62–67PubMed Multon S, Schoenen J (2005) Pain control by vagus nerve stimulation: from animal to man…and back. Acta Neurol Belg 105:62–67PubMed
8.
go back to reference Leone M, Proietti Cecchini A, Mea E, D’Amico D, Tullo V, Grazzi L, Bussone G (2008) Therapeutic neurostimulation in chronic headaches: problems of patient selection. Neurol Sci 29(Suppl 1):S59–S61PubMedCrossRef Leone M, Proietti Cecchini A, Mea E, D’Amico D, Tullo V, Grazzi L, Bussone G (2008) Therapeutic neurostimulation in chronic headaches: problems of patient selection. Neurol Sci 29(Suppl 1):S59–S61PubMedCrossRef
9.
go back to reference Hord ED, Evans MS, Mueed S, Adamolekun B, Naritoku DK (2003) The effect of vagus nerve stimulation on migraines. J Pain 4(9):530–534PubMedCrossRef Hord ED, Evans MS, Mueed S, Adamolekun B, Naritoku DK (2003) The effect of vagus nerve stimulation on migraines. J Pain 4(9):530–534PubMedCrossRef
10.
go back to reference Heck C, Helmers SL, DeGiorgio CM (2002) Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 59(6 Suppl 4):S31–S37PubMed Heck C, Helmers SL, DeGiorgio CM (2002) Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 59(6 Suppl 4):S31–S37PubMed
Metadata
Title
Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data
Authors
Alberto Proietti Cecchini
Eliana Mea
Vincenzo Tullo
Marcella Curone
Angelo Franzini
Giovanni Broggi
Mario Savino
Gennaro Bussone
Massimo Leone
Publication date
01-05-2009
Publisher
Springer Milan
Published in
Neurological Sciences / Issue Special Issue 1/2009
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-009-0073-3

Other articles of this Special Issue 1/2009

Neurological Sciences 1/2009 Go to the issue

ANIRCEF – HCNE Joint Meeting

Local therapies in migraine

Secondary Headaches

Migraine as a visceral pain

ANIRCEF – HCNE Joint Meeting

Antimigraine drugs: new frontiers